Clinical trials for minimally invasive therapy procedures using advanced imaging from Philips Lung Suite start with successful first cases
Arctoris and Evariste Technologies announce a joint venture to develop novel small molecule kinase inhibitors for non-small cell lung cancer (NSCLC)
Collaboration aims to capture patient-to-patient variability to determine the best treatment for every cancer
Tepmetko is the first and only oral MET inhibitor to be approved in the European Economic Area for treating adult patients with advanced NSCLC harboring alterations leading to METex14 skipping, who require systemic therapy following prior treatment
First Positive Study for KEYTRUDA in Adjuvant Stage IB-IIIA NSCLC
After double lung transplantation, he was discharged without supplemental oxygen on the eleventh day
Cryo-technology helps in early diagnosis and palliative care in later stages of cancer
It provides an option to automatically perform nodule detection immediately after chest X-ray imaging
Tecentriq is the first and only cancer immunotherapy approved for NSCLC in the adjuvant setting
The boy becomes India’s youngest recipient to undergo bilateral lung transplantation.
Subscribe To Our Newsletter & Stay Updated
